Aquinox Pharmaceuticals' Unattributed VC Round

Aquinox Pharmaceuticals raised a round of funding on September 23, 2011.

Aquinox Pharmaceuticals engages in the discovery and development of first-in-class, small molecule therapeutics targeting SH2-containing inositol-5'-phosphatase (SHIP1) for the treatment of inflammato…

Articles about Aquinox Pharmaceuticals' Unattributed VC Round: